Options Trading News

September 30, 2013  Mon 7:32 AM CT


Liver Complications Won't Go Away

Achillion Pharmaceuticals said the U.S. Food & Drug Administration kept its experimental hepatitis C drug sovaprevir on hold. The company had tried to address regulators' concerns earlier in the year, but liver complications remain a problem. ACHN plunges more than 50 percent before the opening bell on my tradeMONSTER platform.

Morgan Stanley Downgrades Panera

Panera Bread was downgraded to "equal weight" from "overweight" by Morgan Stanley, which says Chipotle Mexican Grill might do a better job driving sales. PNRA falls 2 percent in the premarket and CMG inches higher.

Share this article with your friends


Premium Services

Education & Strategy

The art of trading

As I stated in last week's article, a break out or a break down needs to have a couple things happen before it is considered a confirmed break out or break down. The only problem is that in today's market where things move much more quicker than they did just a few years ago, two days could wind up being the majority of the expected movement, if not the whole movement.

View more education articles »